|
Medical News Using Respondent-Driven Sampling in a Hidden Population at Risk of HIV Infection: Who Do HIV-Positive Recruiters Recruit?March 26, 2010 Respondent-driven sampling (RDS), a network-based method used to recruit hidden populations, is prone to bias. "However, these biases could facilitate recruitment of high-risk networks," according to the authors, who examined recruitment patterns of HIV-positive injection drug users (IDUs) and identified factors associated with being recruited by an HIV-positive IDU in an RDS-based study. In Tijuana, RDS was used to recruit resident IDUs, age 18 and older, who reported injecting the previous month. Participants underwent interviews and testing for HIV, syphilis, and tuberculosis. Predictors of being recruited by an HIV-positive IDU were identified using weighted logistic regression. Among the 1,056 IDUs, HIV-positive persons comprised 4.4 percent of the sample and generated 4.7 percent of recruits, "indicating that recruitment effectiveness did not vary by HIV status," the authors wrote. "However, 10 percent of the subjects recruited by HIV-positive recruiters were infected with HIV as compared to 4.1 percent of subjects recruited by HIV-negative recruiters (P=0.06), a difference that, after controlling for whether the recruiter and recruit injected drugs together, attained statistical significance (P=0.04), indicating that recruitment patterns differed by HIV status." "HIV-positive IDUs have different recruitment patterns than HIV-negative IDUs, with HIV-positive IDUs tending to recruit other HIV-positive IDUs," the authors concluded. "Social and environmental factors along with risk behaviors were independently associated with being the recruit of an HIV-positive IDU in Tijuana. Although the goal of this study was not to recruit HIV-positive or other high-risk persons, our results suggest that RDS has the potential to successfully be used in the identification of HIV-positive or other high-risk individuals." Sexually Transmitted Diseases 12.2009; Vol. 36; No. 12: P. 750-756, Daniela Abramovitz; Erik M. Volz; Steffanie A. Strathdee; Thomas L. Patterson; Alicia Vera; Simon D.W. Frost; for Proyecto ElCuete This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|